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Figure 1(A) A timeline over the study. (B) Scatter plots over individual
cytokine concentrations at ﬁrst (þ) and second (x) examinations with box
plots summarizing the examinations using the timeline as x-axis. Boxes
represent the median and quartiles, whiskers the 10th and 90th percen-
tiles, and the box widths the relative sample sizes at the two examina-
tions. Tables show median (25th and 75th percentiles) concentrations with
p-values from related-samples Wilcoxon signed-rank test from compar-
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A50signaling pathway led to increased expression of various MMPs, that we
should be able to decrease the expression of MMPs by blocking theWnt
signaling pathway. Immediate inhibition of Wnt signaling in human OA
synovium by addition of FrzB, a general Wnt inhibitor, or DKK-1,
selectively blocking canonical Wnt signaling, led to signiﬁcantly
decreased expression of MMP1, MMP3, MMP9 and MMP13. In contrast,
increased Wnt signaling did not result in an upregulation of S100
proteins.
Conclusions: S100 proteins are able to increase Wnt signaling. Can-
onical Wnts produced in the synovium may play an important role in
OA pathology. Stimulation of human OA synoviumwith Wnts increases
the expression of MMPs, whereas blockingWnt signaling in OA synovial
tissue results in decreased expression of MMPs. This underlines
increased Wnt signaling during OA to be a potential target for therapy.
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ASSOCIATION BETWEEN TISSUE-INFLAMMATION BIOMARKERS AND
PROGRESSION OF OSTEOARTHRITIS: EVIDENCE FROM THE
ROTTERDAM STUDY
F. Saberi Hosnijeh y, A. Siebuhr z, A. Uitterlinden y, A. Hofman y,
M. Karsdal z, S. Bierma-Zeinstra y, A. Bay-Jensen z, J. van Meurs y.
y Erasmus Med. Ctr., Rotterdam, Netherlands; zNordic BioSci., Herlev,
Denmark
Purpose: To investigate the prognostic value of matrix metal-
loproteinase (MMP)-dependent degradation of C reactive protein (CRP)
(CRPM) and connective tissue type I collagen turnover (C1M) on the
incidence and progression of radiographic osteoarthritis (OA) of the
knee and hip in the Rotterdam Study. Moreover, independent effect of
these biomarkers to the established biomarkers of OA progression, type
II collagen degradation (CTX-II) and serum cartilage oligomeric protein
(COMP), was evaluated.
Methods: Serum levels of C1M, CRPM, COMP and CRP of 1335 partic-
ipants aged >55 years were measured in fasting serum using ELISA. The
commercial ELISA detecting CTX-II was used in urine (uCTX-II). X-rays at
baseline and 5 years follow-upwere scored for radiographic OA stage by
Kellgren-Lawrence grade. The associations between OA and the bio-
markers were examined using logistic regression and generalized
estimating equations adjusted for age, sex, BMI, and possible other
confounders. Prediction value of the biomarkers was evaluated com-
pared with demographic characteristics and joint pain.
Results: The uCTX-II and COMP concentrations were associated with
the prevalence, incidence, and progression of OA. C1M, CRPM and CRP
were not associated with prevalence of OA. However, higher levels of
CRP were associated with incidence risk of knee and hip OA. Moreover,
OA progression was positively associated with CRPM (OR¼1.2, 95%
CI¼1-1.5, p¼0.04) and CRP (OR¼1.3, 95%CI¼1-1.6, p¼0.03) levels
independent of uCTX-II and COMP.
Conclusions: Our study conﬁrmed the associations between uCTX-II
and COMP concentrations and hip OA and/or knee OA progression.
Moreover, we showed for the ﬁrst time that a MMP-dependent tissue-
inﬂammation marker predicts the risk of OA progression independent
of established biomarkers uCTX-II and COMP.
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INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR ALPHA IN
SYNOVIAL FLUID ARE ASSOCIATED WITH PROGRESSION OF
RADIOGRAPHIC OSTEOARTHRITIS IN SUBJECTS WITH PREVIOUS
MENISCECTOMY
S. Larsson y, M. Englund y,z, A. Struglics y, S. Lohmander y,x.
yOrthopaedics, Dept. of Clinical Sci. Lund, Lund Univ., Lund, Sweden;
zClinical Epidemiology Res. & Training Unit, Boston Univ. Sch. of Med.,
Boston, MA, United States; xRes. Unit for Musculoskeletal Function and
Physiotherapy and Dept. of Orthopaedics and Traumatology, Univ. of
Southern Denmark, Odense, Denmark
Purpose: To investigate in an exploratory study whether synovial ﬂuid
concentrations of pro-inﬂammatory cytokines, or changes in concen-
tration over time, are associated with progression of radiographic knee
osteoarthritis (OA) and patient-reported outcomes in subjects with
previous meniscectomy.
Methods: We studied 132 subjects at two time points after menis-
cectomy. At ﬁrst examination they were mean (range) 52 (32-73) years
old and had been meniscectomized 18 (15-22) years earlier, with asecond examination 7.5 (4-10) years later (Fig. 1A). We obtained
synovial ﬂuid, patient-reported outcomes, semiﬂexed weightbearing
tibiofemoral and skyline patellofemoral radiographs at both exami-
nations; 71 subjects had synovial ﬂuid available from both examina-
tions. We measured synovial ﬂuid concentrations of interleukin (IL)-6,
IL-8 and tumor necrosis factor (TNF)-a by a multiplex immunoassay
(Meso Scale Discovery). Radiographs were read according to the OARSIisons of cytokine levels at ﬁrst and second examinations.
Table 1
Cytokines as predictors of progression of outcomes of osteoarthritis. Odds ratios (OR) with 95% conﬁdence intervals (CI) from logistic regression analysis with adjustments for
sex, age and body mass index at ﬁrst examination, and time between examinations. Statistically signiﬁcant associations are indicated in bold.
Synovial ﬂuid conc.
exam 1 (n ¼ 132)
Synovial ﬂuid conc.
exam 2 (n ¼ 71)
Delta conc.
(2e1) (n ¼ 71)
Increased conc.
(2 > 1) (n ¼ 71)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Radiographic progression
Loss of joint space IL-6
IL-8
TNF-a
1.02 (0.99, 1.06)
1.04 (0.99, 1.09)
1.01 (0.80, 1.28)
1.00 (1.00, 1.01)
1.00 (1.00, 1.01)
1.70 (1.15, 2.52)
1.00 (1.00, 1.01)
1.00 (0.99, 1.01)
1.34 (1.06, 1.71)
5.17 (1.54, 17.32)
2.37 (0.65, 8.61)
5.01 (1.32, 18.92)
Osteophyte progression IL-6
IL-8
TNF-a
1.05 (1.00, 1.09)
1.05 (0.99, 1.10)
1.35 (1.03, 1.75)
1.00 (1.00, 1.01)
1.00 (0.99, 1.01)
1.05 (0.82, 1.36)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
0.90 (0.73, 1.11)
1.51 (0.49, 4.66)
1.33 (0.37, 4.79)
0.71 (0.22, 2.35)
ROA progression IL-6
IL-8
TNF-a
1.05 (0.98, 1.13)
1.03 (0.97, 1.10)
1.24 (0.90, 1.70)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.27 (0.91, 1.76)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.07 (0.84, 1.37)
2.70 (0.80, 9.13)
2.73 (0.67, 11.03)
1.41 (0.36, 5.55)
KOOS progression
Pain IL-6
IL-8
TNF-a
1.01 (0.99, 1.03)
1.02 (0.97, 1.08)
1.12 (0.87, 1.44)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.16 (0.88, 1.54)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.11 (0.88, 1.38)
1.02 (0.29, 3.52)
1.29 (0.30, 5.64)
1.72 (0.40, 7.34)
Other symptoms IL-6
IL-8
TNF-a
1.00 (0.98, 1.02)
1.00 (0.95, 1.06)
1.08 (0.84, 1.40)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
0.97 (0.72, 1.31)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
0.99 (0.79, 1.24)
1.71 (0.46, 6.37)
1.63 (0.37, 7.16)
1.27 (0.32, 5.04)
Function of daily living IL-6
IL-8
TNF-a
1.01 (1.00, 1.03)
1.04 (0.99, 1.10)
1.18 (0.90, 1,55)
1.01 (1.00, 1.01)
1.00 (0.99, 1.01)
1.50 (1.07, 2.09)
1.01 (1.00, 1.01)
1.00 (0.99, 1.01)
1.25 (0.97, 1.62)
0.97 (0.24, 3.89)
0.99 (0.21, 4.57)
7.25 (0.81, 65.33)
Function in sports
and recreation
IL-6
IL-8
TNF-a
1.08 (1.01, 1.14)
1.04 (0.98, 1.09)
1.06 (0.83, 1.36)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.17 (0.89, 1.53)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
1.09 (0.88, 1.34)
1.29 (0.38, 4.32)
1.24 (0.33, 4.67)
1.65 (0.45, 6.09)
Knee-related quality of life IL-6
IL-8
TNF-a
1.02 (0.99, 1.04)
1.03 (0.98, 1.08)
1.16 (0.90, 1.48)
1.00 (1.00, 1.01)
1.00 (0.99, 1.01)
0.81 (0.58, 1.11)
1.00 (0.99, 1.01)
1.00 (0.99, 1.01)
0.83 (0.65, 1.06)
0.73 (0.21, 2.57)
0.67 (0.18, 2.53)
0.86 (0.23, 3.19)
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A51atlas with loss of joint space and osteophyte progression evaluated
separately as well as combined (to a radiographic score). Progression
from ﬁrst to second examination was deﬁned by increase of one or
more in grade or score. We evaluated patient-reported outcomes by
separate analysis of the ﬁve subscales of the Knee injury and Osteo-
arthritis Outcome Score (KOOS; Table 1), with progression deﬁned as a
worsening in the subscale score by 10 units or more. To study asso-
ciations between cytokine concentrations and progression of out-
comes, we used multivariate logistic regression analysis. The odds
ratios (OR) reﬂect higher concentration, or change in concentration
between visits, in increments of 1 pg/ml, or having increased in con-
centration or not. We did not use multiple test adjustments due to the
exploratory character of the study.
Results: At group level, synovial ﬂuid concentrations of IL-6, IL-8 and
TNF-a all increased between examinations (Fig. 1B). At the ﬁrst
examination, there was an overall trend for increased likelihood of
progression of radiographic features of OA in the subsequent years
with higher synovial ﬂuid cytokine levels (mean OR 1.1; Table 1). This
was most pronounced for osteophytes, for which higher concen-
trations of IL-6 (OR 1.05) and TNF-a (OR 1.35) were associated with
progression (Table 1). For patient-relevant outcomes, the only asso-
ciation found was between IL-6 and worsening of the KOOS domain
Sports and Recreation (OR 1.08; Table 1). At the second examination,
higher concentrations of TNF-a (but not IL-6 and IL-8) was associated
with having progressed in loss of joint space (OR 1.70) or worsened
in function of daily living (OR 1.50) in the preceding years (Table 1).
We further found that for the change in cytokine concentrations
between examinations, increase in TNF-a (but not in IL-6 or IL-8) was
associated with progression of loss of joint space (OR 1.34; Table 1).
With change in cytokine concentrations dichotomized as ‘increasing
vs. not increasing’, we found that those who had increased in con-
centrations of IL-6 or TNF-a from ﬁrst to second examination had a
5-fold increased likelihood of having progressed in loss of joint space
as compared to those with stable or decreasing concentrations
(Table 1).
Conclusions: In middle-aged subjects with previous meniscectomy,
having high or over time increasing synovial ﬂuid levels of IL-6 and TNF-
a was associated with increased risk for progression of radiographic
features of OA over four to ten years. Although our results need con-
ﬁrmation in prospective studies, they indicate that IL-6 or TNF-a may
represent valid treatment targets in knee OA.46
ELEVATED PERIPHERAL BLOOD LEUKOCYTE INFLAMMATORY GENE
EXPRESSION IN RADIOGRAPHIC PROGRESSORS WITH
SYMPTOMATIC KNEE OSTEOARTHRITIS: NYU AND OAI COHORTS
M. Attur y, A. Statnikov z, S. Krasnokutsky y, V. Kraus x, J.M. Jordan k,
B.D. Mitchell ¶, M. Yau#, J. Patel y, C.F. Aliferis z, M. Hochberg#,
J. Samuels y, S.B. Abramson y. yNYU-Hosp. for Joint Diseases, New York,
NY, United States; zCtr. for Hlth.Informatics and Bioinformatics, NYU
Langone Med. Ctr., New York, NY, United States; xDuke Univ. Sch. of
Med., Durham, NC, United States; k Thurston Arthritis Res. Ctr., Univ. of
North Carolina, Chapel Hill, NC, United States; ¶Depts of Med. and
Epidemiology & Publ. Hlth., Univ. of Maryland Sch. of Med., Baltimore,
MD, United States; #Depts of Med. and Epidemiology & Publ. Hlth.,
Univ. of Maryland Sch. of Med., Baltimore, Baltimore, MD, United States
Purpose: We and others have demonstrated low grade inﬂammation
exists in OA joint tissues, where it may contribute to disease patho-
genesis. In the current studies we assessed whether inﬂammatory
events occurring within joint tissues were reported in the peripheral
blood leukocytes (PBLs) of patients with symptomatic knee OA (SKOA).
Methods: PBL inﬂammatory gene expression (IL-1, TNFa, COX-2) was
assessed in two independent cohorts of patients with SKOA, and a
cohort of healthy control subjects: 1) 111 patients with tibiofemoral
medial OA and 21 healthy volunteers from the NYUHJD Cohort, and 2)
200 patients from the OAI progression cohort who had “high quality
radiographs”, at both baseline and 24 months, and had KL2 or 3 in the
signal knee at baseline. Radiographic progression was deﬁned as nar-
rowing of medial joint space width (JSW) in the signal knee between
baseline and 24-months in each cohort. Radiographic progressors were
deﬁned as subjects who had JSN >0.0, 0.2 and 0.5mm over 24 months.
For measuring predictive performance, we used the area under the
curve (AUC) of a receiver operating characteristics (ROC). OAI SKOA
subjects were dichotomized as radiographic non-progressors (JSN <0.0
mm) and progressors (JSN>0.0mm) for association studies.
Results: Elevated PBL expression of IL-1, TNFa or COX-2 identiﬁed SKOA
patients who were “fast progressors” (mean JSN 0¼ 0.71, 0.75 and 0.71
mm / 24 months, respectively) compared to patients with levels below
the median. In a multivariable model, anthropometric traits alone (BMI,
gender, age) did not predict progression, whereas addition of PBL gene
expressions improved prediction of fast progressors (JSN>0.5mm). We
next examined inﬂammatory gene expression in PBLs of radiographic
